367 related articles for article (PubMed ID: 9583726)
1. Correlation of the immunohistochemical reactivity of mucin peptide cores MUC1 and MUC2 with the histopathological subtype and prognosis of gastric carcinomas.
Baldus SE; Zirbes TK; Engel S; Hanisch FG; Mönig SP; Lorenzen J; Glossmann J; Fromm S; Thiele J; Pichlmaier H; Dienes HP
Int J Cancer; 1998 Apr; 79(2):133-8. PubMed ID: 9583726
[TBL] [Abstract][Full Text] [Related]
2. Expression of MUC1 and MUC2 mucins in gastric carcinomas: their relationship with clinicopathologic parameters and prognosis.
Akyürek N; Akyol G; Dursun A; Yamaç D; Günel N
Pathol Res Pract; 2002; 198(10):665-74. PubMed ID: 12498221
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of MUC1, MUC2 and MUC5AC expressions in gastric carcinoma.
İlhan Ö; Han Ü; Önal B; Çelık SY
Turk J Gastroenterol; 2010 Dec; 21(4):345-52. PubMed ID: 21331986
[TBL] [Abstract][Full Text] [Related]
4. Relationship between immunoexpression of mucin peptide cores MUC1 and MUC2 and Lauren's histologic subtypes of gastric carcinomas.
Barresi V; Vitarelli E; Grosso M; Tuccari G; Barresi G
Eur J Histochem; 2006; 50(4):301-9. PubMed ID: 17213039
[TBL] [Abstract][Full Text] [Related]
5. Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression.
Reis CA; David L; Correa P; Carneiro F; de Bolós C; Garcia E; Mandel U; Clausen H; Sobrinho-Simões M
Cancer Res; 1999 Mar; 59(5):1003-7. PubMed ID: 10070955
[TBL] [Abstract][Full Text] [Related]
6. Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients.
Utsunomiya T; Yonezawa S; Sakamoto H; Kitamura H; Hokita S; Aiko T; Tanaka S; Irimura T; Kim YS; Sato E
Clin Cancer Res; 1998 Nov; 4(11):2605-14. PubMed ID: 9829723
[TBL] [Abstract][Full Text] [Related]
7. Expression of mucins and E-cadherin in gastric carcinoma and their clinical significance.
Zhang HK; Zhang QM; Zhao TH; Li YY; Yi YF
World J Gastroenterol; 2004 Oct; 10(20):3044-7. PubMed ID: 15378790
[TBL] [Abstract][Full Text] [Related]
8. MUC5B expression in gastric carcinoma: relationship with clinico-pathological parameters and with expression of mucins MUC1, MUC2, MUC5AC and MUC6.
Pinto-de-Sousa J; Reis CA; David L; Pimenta A; Cardoso-de-Oliveira M
Virchows Arch; 2004 Mar; 444(3):224-30. PubMed ID: 14758553
[TBL] [Abstract][Full Text] [Related]
9. Expression of mucin antigens in human cancers and its relationship with malignancy potential.
Yonezawa S; Sato E
Pathol Int; 1997 Dec; 47(12):813-30. PubMed ID: 9503463
[TBL] [Abstract][Full Text] [Related]
10. Expression of epithelial mucins Muc1, Muc2, and Muc3 in ductal carcinoma in situ of the breast.
Diaz LK; Wiley EL; Morrow M
Breast J; 2001; 7(1):40-5. PubMed ID: 11348414
[TBL] [Abstract][Full Text] [Related]
11. Immunoreactivity of Lewis blood group and mucin peptide core antigens: correlations with grade of dysplasia and malignant transformation in the colorectal adenoma-carcinoma sequence.
Baldus SE; Hanisch FG; Pütz C; Flucke U; Mönig SP; Schneider PM; Thiele J; Hölscher AH; Dienes HP
Histol Histopathol; 2002 Jan; 17(1):191-8. PubMed ID: 11813869
[TBL] [Abstract][Full Text] [Related]
12. Expression of MUC1 and MUC2 mucin gene products in human ovarian carcinomas.
Feng H; Ghazizadeh M; Konishi H; Araki T
Jpn J Clin Oncol; 2002 Dec; 32(12):525-9. PubMed ID: 12578901
[TBL] [Abstract][Full Text] [Related]
13. How do gastric carcinoma classification systems relate to mucin expression patterns? An immunohistochemical analysis in a series of advanced gastric carcinomas.
Gürbüz Y; Kahlke V; Klöppel G
Virchows Arch; 2002 May; 440(5):505-11. PubMed ID: 12021925
[TBL] [Abstract][Full Text] [Related]
14. MUC1, MUC2, MUC5AC, and MUC6 expressions in gastric carcinomas: their roles as prognostic indicators.
Lee HS; Lee HK; Kim HS; Yang HK; Kim YI; Kim WH
Cancer; 2001 Sep; 92(6):1427-34. PubMed ID: 11745219
[TBL] [Abstract][Full Text] [Related]
15. Immunoreactivity of cytokeratins (CK7, CK20) and mucin peptide core antigens (MUC1, MUC2, MUC5AC) in adenocarcinomas, normal and metaplastic tissues of the distal oesophagus, oesophago-gastric junction and proximal stomach.
Flucke U; Steinborn E; Dries V; Mönig SP; Schneider PM; Thiele J; Hölscher AH; Dienes HP; Baldus SE
Histopathology; 2003 Aug; 43(2):127-34. PubMed ID: 12877727
[TBL] [Abstract][Full Text] [Related]
16. Immunoreactivity of monoclonal antibody BW835 represents a marker of progression and prognosis in early gastric cancer.
Baldus SE; Zirbes TK; Glossmann J; Fromm S; Hanisch FG; Mönig SP; Schröder W; Schneider PM; Flucke U; Karsten U; Thiele J; Hölscher AH; Dienes HP
Oncology; 2001; 61(2):147-55. PubMed ID: 11528254
[TBL] [Abstract][Full Text] [Related]
17. Expression of MUC1 and MUC2 mucins in extrahepatic bile duct carcinomas: its relationship with tumor progression and prognosis.
Tamada S; Goto M; Nomoto M; Nagata K; Shimizu T; Tanaka S; Sakoda K; Imai K; Yonezawa S
Pathol Int; 2002 Nov; 52(11):713-23. PubMed ID: 12685548
[TBL] [Abstract][Full Text] [Related]
18. Comparative evaluation of the prognostic value of MUC1, MUC2, sialyl-Lewis(a) and sialyl-Lewis(x) antigens in colorectal adenocarcinoma.
Baldus SE; Mönig SP; Hanisch FG; Zirbes TK; Flucke U; Oelert S; Zilkens G; Madejczik B; Thiele J; Schneider PM; Hölscher AH; Dienes HP
Histopathology; 2002 May; 40(5):440-9. PubMed ID: 12010364
[TBL] [Abstract][Full Text] [Related]
19. Mucins MUC1, MUC2, MUC5AC and MUC6 expression in the evaluation of differentiation and clinico-biological behaviour of gastric carcinoma.
Pinto-de-Sousa J; David L; Reis CA; Gomes R; Silva L; Pimenta A
Virchows Arch; 2002 Mar; 440(3):304-10. PubMed ID: 11889602
[TBL] [Abstract][Full Text] [Related]
20. Co-expression of CDX2 and MUC2 in gastric carcinomas: correlations with clinico-pathological parameters and prognosis.
Roessler K; Mönig SP; Schneider PM; Hanisch FG; Landsberg S; Thiele J; Hölscher AH; Dienes HP; Baldus SE
World J Gastroenterol; 2005 Jun; 11(21):3182-8. PubMed ID: 15929165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
